Status:

COMPLETED

The Effect of Losartan and Losartan Plus Isosorbide Mononitrate on Central Blood Pressure Measurements (0954-317)

Lead Sponsor:

Organon and Co

Conditions:

Hypertension

Eligibility:

All Genders

45-70 years

Phase:

PHASE1

Brief Summary

This study will qualify a functional model that can measure central blood pressure and vascular compliance effects through noninvasive means.

Eligibility Criteria

Inclusion

  • Patient is in good health with the exception of mild to moderate hypertension
  • Patient is willing to comply with the study restrictions
  • Patient does not smoke

Exclusion

  • Patient has a history of any illness that might confound the results of the study or make participation in the study unsafe
  • Patient is taking a prescription medication that is contraindicated for use with COZAAR® or IMDUR®
  • Patient has a condition for which there is a warning, contraindication, or precaution against the use of COZAAR® or IMDUR®

Key Trial Info

Start Date :

August 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2006

Estimated Enrollment :

13 Patients enrolled

Trial Details

Trial ID

NCT00943852

Start Date

August 1 2006

End Date

December 1 2006

Last Update

February 9 2022

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

The Effect of Losartan and Losartan Plus Isosorbide Mononitrate on Central Blood Pressure Measurements (0954-317) | DecenTrialz